Literature DB >> 23569724

Assessment of in vitro sensitivity of Plasmodium vivax fresh isolates.

Poonuch Muhamad1, Wanna Chacharoenkul, Kanchana Rungsihirunrat, Ronnatrai Ruengweerayut, Kesara Na-Bangchang.   

Abstract

OBJECTIVE: To compare the applicability of the SYBR Green-I assay with the standard schizont maturation assay, for determination of sensitivity of Plasmodium vivax (P. vivax) to chloroquine and a new antifolate WR 99210.
METHODS: The study was conducted at Mae Tao Clinic for migrant workers, Tak Province during April 2009 to July 2010. A total of 64 blood samples (1 mL blood collected into sodium heparinized plastic tube) were collected from patients with mono-infection with P. vivax malaria prior to treatment with standard regimen of a 3-day chloroquine. In vitro sensitivity of P. vivax isolates was evaluated by schizont maturation inhibition and SYBR Green-I assays.
RESULTS: A total of 30 out of 64 blood samples collected from patients with P. vivax malaria were successfully analyzed using both the microscopic schizont maturation inhibition and SYBR Green-I assays. The failure rates of the schizont maturation inhibition assay (50%) and the SYBR Green-I assay (54%) were similar (P=0.51). The median IC10s, IC50s and IC90s of both chloroquine and WR99210 were not significantly different from the clinical isolates of P. vivax tested. Based on the cut-off of 100 nM, the prevalences of chloroquine resistance determined by schizont maturation inhibition and SYBR Green-I assays were 19 and 11 isolates, respectively. The strength of agreement between the two methods was very poor for both chloroquine and WR99210.
CONCLUSIONS: On the basis of this condition and its superior sensitivity, the microscopic method appears better than the SYBR Green-I Green assay for assessing in vitro sensitivity of fresh P. vivax isolates to antimalarial drugs.

Entities:  

Keywords:  Antifolate; Antimalarial drug; Chloroquine; Fresh isolate; In vitro sensitivity; Malaria; Plasmodium vivax; SYBR Green-I assay; Schizont maturation inhibition assay; Standard regimen

Mesh:

Substances:

Year:  2011        PMID: 23569724      PMCID: PMC3609160          DOI: 10.1016/S2221-1691(11)60067-1

Source DB:  PubMed          Journal:  Asian Pac J Trop Biomed        ISSN: 2221-1691


  18 in total

Review 1.  Malaria drug-sensitivity testing: new assays, new perspectives.

Authors:  Harald Noedl; Chansuda Wongsrichanalai; Walther H Wernsdorfer
Journal:  Trends Parasitol       Date:  2003-04

2.  Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system.

Authors:  Michele D Hastings; Jason D Maguire; Michael J Bangs; Peter A Zimmerman; John C Reeder; J Kevin Baird; Carol Hopkins Sibley
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

3.  Conflicting requirements of Plasmodium falciparum dihydrofolate reductase mutations conferring resistance to pyrimethamine-WR99210 combination.

Authors:  Deanpen Japrung; Ubolsree Leartsakulpanich; Sudsanguan Chusacultanachai; Yongyuth Yuthavong
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

4.  Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy.

Authors:  Tyler N Bennett; Michelle Paguio; Bojana Gligorijevic; Clement Seudieu; Andrew D Kosar; Eugene Davidson; Paul D Roepe
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

5.  Clinical-parasitological response and in-vitro sensitivity of Plasmodium vivax to chloroquine and quinine on the western border of Thailand.

Authors:  Oumaporn Tasanor; Ronnatrai Ruengweerayut; Jeerapat Sirichaisinthop; Kanungnit Congpuong; Walther H Wernsdorfer; Kesara Na-Bangchang
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-02-23       Impact factor: 2.184

6.  Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates.

Authors:  Varakorn Kosaisavee; Rossarin Suwanarusk; François Nosten; Dennis E Kyle; Marion Barrends; James Jones; Ric Price; Bruce Russell; Usa Lek-Uthai
Journal:  Exp Parasitol       Date:  2006-03-20       Impact factor: 2.011

7.  Sensitivity to antifolates and genetic analysis of Plasmodium vivax isolates from Thailand.

Authors:  Kanchana Rungsihirunrat; Kesara Na-Bangchang; Vivian N Hawkins; Mathirut Mungthin; Carol Hopkins Sibley
Journal:  Am J Trop Med Hyg       Date:  2007-06       Impact factor: 2.345

8.  Determinants of in vitro drug susceptibility testing of Plasmodium vivax.

Authors:  B Russell; F Chalfein; B Prasetyorini; E Kenangalem; K Piera; R Suwanarusk; A Brockman; P Prayoga; P Sugiarto; Q Cheng; E Tjitra; N M Anstey; R N Price
Journal:  Antimicrob Agents Chemother       Date:  2008-01-07       Impact factor: 5.191

Review 9.  Cultivation of Plasmodium vivax.

Authors:  Rachanee Udomsangpetch; Osamu Kaneko; Kesinee Chotivanich; Jetsumon Sattabongkot
Journal:  Trends Parasitol       Date:  2008-01-03

10.  Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates.

Authors:  Marie Ange Rason; Tantely Randriantsoa; Herilalaina Andrianantenaina; Arsène Ratsimbasoa; Didier Menard
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-03-05       Impact factor: 2.184

View more
  2 in total

1.  Effect of insulin on Blattela germanica Linnacus.

Authors:  E Abolghasemi; Kazem S H Moosa; M Abolhasani; M Davoudi
Journal:  Asian Pac J Trop Biomed       Date:  2011-08

2.  Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.

Authors:  Lilia Gonzalez-Ceron; Mario H Rodriguez; Marco A Sandoval; Frida Santillan; Sonia Galindo-Virgen; Angel F Betanzos; Angel F Rosales; Olga L Palomeque
Journal:  Malar J       Date:  2015-10-30       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.